Valuation: DiaSorin S.p.A.

Capitalization 323.83Cr 380.13Cr 299.7Cr 282.19Cr 525.62Cr 35TCr 536.38Cr 3.52TCr 1.38TCr 17TCr 1.43TCr 1.4TCr 60TCr P/E ratio 2026 *
17.5x
P/E ratio 2027 * 15.3x
Enterprise value 388.72Cr 456.3Cr 359.74Cr 338.73Cr 630.93Cr 42TCr 643.86Cr 4.22TCr 1.65TCr 20TCr 1.71TCr 1.68TCr 73TCr EV / Sales 2026 *
3.15x
EV / Sales 2027 * 2.81x
Free-Float
37.75%
Yield 2026 *
2.11%
Yield 2027 * 2.35%
1 day-1.41%
1 week+1.45%
Current month+0.43%
1 month-5.88%
3 months-19.53%
6 months-19.47%
Current year-12.21%
1 week 57.24
Extreme 57.24
61.88
1 month 52.34
Extreme 52.34
65.56
Current year 52.34
Extreme 52.34
77.64
1 year 52.34
Extreme 52.34
101.6
3 years 52.34
Extreme 52.34
112.35
5 years 52.34
Extreme 52.34
208.8
10 years 49.85
Extreme 49.85
211.8
Manager TitleAgeSince
Chief Executive Officer 60 26/03/2007
Corporate Officer/Principal 63 29/04/2022
Investor Relations Contact - -
Director TitleAgeSince
Director/Board Member 60 28/04/2016
Director/Board Member 63 26/03/2007
Chairman 57 29/04/2022
Change 5d. change 1-year change 3-years change Capi.($)
-1.41%+1.45%-37.30%-39.21% 380.13Cr
-1.33%-2.73%-22.54%-9.70% 1.25TCr
-9.83%-16.23%+79.82%+220.95% 1.03TCr
+5.39%+14.32%+156.14%+106.66% 570.38Cr
+0.09%-1.40%-12.02%-19.65% 533.95Cr
-1.03%+5.90%-20.99%-5.72% 523.61Cr
-5.99%-6.43% - - 510.06Cr
+1.17%+4.21%+190.51%-55.89% 297.28Cr
+0.32%+1.62%-18.25%-42.33% 288.98Cr
+1.09%+1.37%+35.07%+55.98% 192.36Cr
Average -1.15%-0.12%+38.94%+23.45% 557.66Cr
Weighted average by Cap. -2.18%-2.23%+33.50%+45.40%

Financials

2026 *2027 *
Net sales 123.58Cr 145.06Cr 114.37Cr 107.69Cr 200.58Cr 13TCr 204.69Cr 1.34TCr 524.97Cr 6.48TCr 544.38Cr 532.84Cr 23TCr 132.65Cr 155.71Cr 122.76Cr 115.59Cr 215.3Cr 14TCr 219.71Cr 1.44TCr 563.5Cr 6.95TCr 584.33Cr 571.95Cr 25TCr
Net income 18Cr 22Cr 17Cr 16Cr 30Cr 2.01TCr 31Cr 200.34Cr 78Cr 967.39Cr 81Cr 80Cr 3.45TCr 22Cr 26Cr 20Cr 19Cr 36Cr 2.4TCr 36Cr 238.49Cr 93Cr 1.15TCr 97Cr 95Cr 4.1TCr
Net Debt 65Cr 76Cr 60Cr 57Cr 105.31Cr 7.08TCr 107.47Cr 704.45Cr 275.64Cr 3.4TCr 285.83Cr 279.77Cr 12TCr 49Cr 57Cr 45Cr 42Cr 79Cr 5.31TCr 81Cr 528.28Cr 206.7Cr 2.55TCr 214.35Cr 209.8Cr 9.09TCr
Logo DiaSorin S.p.A.
DiaSorin S.p.A. specializes in the development, manufacturing and marketing of in vitro diagnostic reagents. The products are used in treating infectious and viral diseases, thyroid pathologies, cancer, etc. At the end of 2024, the group had 10 production sites located in Italy, the United States (6), Canada, Germany, and the United Kingdom.
Employees
3,242
Date Price Change Volume
13/26/13 60.24 -1.41% 76,865
10/26/10 61.10 +0.76% 2,10,217
09/26/09 60.64 0.00% 4,06,623
08/26/08 60.64 +2.12% 3,22,736
Trader
Investor
Global
Quality
ESG MSCI
BBB
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
12
Last Close Price
61.10EUR
Average target price
72.28EUR
Spread / Average Target
+18.29%

Quarterly revenue - Rate of surprise